The hypothesis, based on previous in vivo data, that angiotensin AT1 r
eceptors are regulated by GH or insulin-like growth factor I (IGF-I) h
as been investigated in this study using primary cultures of rat astro
cytes as a model of AT1 receptor expression. At a dose of 1 ng/ml GH,
there was an increase in AT1 density within 4 h and a maximum increase
of 361 +/- 57% of the control value at 12 h. At 24 h, receptor densit
y was still 176 +/- 23% that in the control. Astrocytes incubated with
1 ng/ml rat IGF-I for 24 h showed no change in AT1 receptor density.
Reverse transcriptase-PCR was used to show that astrocytes express bot
h the AT1a receptor subtype and, to a much lesser extent, the AT1b sub
type. Treatment with 1 ng/ml recombinant bovine GH for 12 h increased
the messenger RNA of the AT1a receptor by 170%, without affecting the
AT1b receptor. Inhibition of protein synthesis by cycloheximide and of
transcription by the adenosine analog dichlororibofuranosylbenzimidaz
ole both prevented the increase in AT1 receptor density following GH t
reatment, indicating that the action of GH is transcriptional. In summ
ary, we have shown that GH up-regulates, directly and not via IGF-I, a
ngiotensin receptors of the AT1a subtype in astrocytes by a transcript
ional mechanism. The long latency of the response and the dependency o
n transcription relegate the AT1a gene to the class of GH-regulated ge
nes identified as delayed stable genes. This mechanism of AT1 activati
on may be one way in which GH activates the renin-angiotensin system a
nd initiates consequential cardiovascular and angiogenic effects.